So you never managed to get your hands on any Facebook shares ahead of the social media giant’s IPO, and given some of the prices paid in the secondary markets, maybe that’s not such a bad thing.
You’re fascinated by the rapid advances in health care IT, maybe, intrigued by the notion that thousands of startups will be taking advantage of mobile, or big data, to disrupt the incumbent players—incumbents with deep pockets to buy up the most promising entries.
Ah, but where to start. You’re not a venture capitalist, you’re just an accredited investor looking for the kinds of outsized returns that stocks and bonds aren’t getting.
Last year’s booming secondary market is this year’s existential question: for SharesPost and Second Market, is there life after Facebook? Both companies, which grew quickly along with the private market demand for Facebook shares, are dealing with revenue losses now that Facebook is no longer trading privately.